Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion type Assertion NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_head.
- NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion description "[Recent studies have indicated that cytokines can be used as markers for disease progression in hepatitis C virus (HCV)-infected patients, therefore this study was conducted to determine the influence of pegylated IFN vs standard IFN on interleukin-2 receptor (IL-2R), IL-6R, IL-8, TNFR-I, TNFR-II, sFas, and sFas-L in Egyptian patients with chronic hepatitis C genotype 4, as no previous studies have been performed on this genotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_provenance.
- NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion evidence source_evidence_literature NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_provenance.
- NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion SIO_000772 17576388 NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_provenance.
- NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion wasDerivedFrom befree-20150227 NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_provenance.
- NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_assertion wasGeneratedBy ECO_0000203 NP492990.RATbnuN9-8xtFkanyIMJEkyroBhdaSXSxDclOnl6IyCmk130_provenance.